RNA Manufacturing
Guided Tour Series
| region | na1 |
| portalId | 1769030 |
| formId | 11bdc374-6e4d-4573-9c3e-6729f05df0bc |
| target | services-hubspot-form |
| redirectUrl | https://www.aldevron.com/thank-you-for-downloading-rna-manufacturing-guided-tour-series |
During a recent webinar by Dr. Venkata Indurthi, Chief Scientific Officer at Aldevron, he discussed mRNA/saRNA Manufacturing: Considerations to Accelerate the Path to Clinic, detailing key upstream and downstream considerations needed for process development in RNA drug substance manufacturing.
Questions during the Q&A session covered a range of topics, including:
- Program Development & Support
- Synthesis Process & Methods
- Production & Manufacturing
- Analytics & Testing
- Therapeutic Delivery & Applications
Because of time limitations, Dr. Indurthi was only able to answer a few of the submitted questions. Therefore, we followed up with an interview with Dr. Indurthi, asking him additional questions for publication in this 5-part guided series focusing on the above topics.
You can request your copy of this series to learn more about the key considerations in mRNA/saRNA manufacturing for a successful path to the clinic.
- Request the interview series (return to download page from March-August 2023 for newly released topics)
- View the webinar, mRNA/saRNA Manufacturing: Considerations to Accelerate the Path to Clinic